Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Phase 3 Study of HS-20094 in Patients With T2DM [Phase 3]
This clinical trial update describes a Phase 3 study of HS-20094 in adults with Type 2 diabetes mellitus, which is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education [NA]
A clinical trial update describes a study comparing intermittently scanned continuous glucose monitoring to capillary glucose monitoring whe…
-
CLINICAL_TRIALS other · 2025-09-05Clinical Trial Update: A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone [Phase 3]
A Phase 3 clinical trial update for HS-20094 in adults with Type 2 diabetes mellitus not adequately controlled by diet and exercise; the stu…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
A clinical trial is studying salivary cortisol and hypercortisolism in individuals with type 2 diabetes. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes [NA]
Completed clinical trial evaluating personalized sleep interventions to prevent progression from prediabetes to Type 2 diabetes in community…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol [Phase 4]
This document describes a Phase 4 study protocol assessing empagliflozin in elderly adults with type 2 diabetes, in combination with a Medit…
-
EMA safety_alert · 2025-09-03Warning about sharp rise in illegal medicines sold in the EU
EMA warns that illegal medicines marketed as GLP-1 receptor agonists for weight loss and diabetes are circulating in the EU, posing serious …
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy? [NA]
A completed clinical trial evaluating whether premature aging increases the risk of cardiomyopathy in people with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Strategies to Improve Well-Being and Diabetes Management [NA]
Clinical trial update indicating a recruiting study sponsored by Elizabeth Scharnetzki focused on strategies to improve well-being and manag…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: The Effect of Body Weight on Physical Activity Level, Functional Capacity, Balance, and Quality of Life in Individuals With Type 2 Diabetes Mellitus
This clinical trial update describes a study examining how body weight relates to physical activity, functional capacity, balance, and quali…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: GlucoBites Cookies (Gynura Procumbens) for Glycemic Control and Prevention of Diabetic Foot Ulcer Risk in Type 2 Diabetes [NA]
A planned clinical trial evaluating GlucoBites Cookies containing Gynura procumbens for glycemic control and prevention of diabetic foot ulc…
-
FDA approval · 2025-09-02FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity [Phase 4]
Phase 4 clinical trial evaluating enavogliflozin effects on coronary microvascular and cardiac function in obesity; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Feasibility Of Individualized Dietary Plan (Idp) On Glycemic Control And Total Cholestrol In Diabetic Patients At Diabetes Hospital And Research Centre Peshawar [NA]
A completed clinical trial evaluating the feasibility of an individualized dietary plan to improve glycemic control and total cholesterol in…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus
An ongoing clinical trial evaluating the efficacy and safety of Envlo and Envlomet SR tablets in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus
Registry study update assessing the effectiveness and safety of weight loss with Enavogliflozin in patients with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid [NA]
This clinical trial update notes an ongoing study in general practice testing a digital decision-aid–driven, individualized treatment approa…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
This document provides an update on a clinical trial evaluating the effect of linking data via the smartphone app 'Well Check' on clinical o…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D] [NA]
EMPOWER-D is an ongoing clinical trial in Pakistan evaluating community-based participatory learning and action to control Type 2 diabetes a…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) [NA]
This clinical trial update indicates that Signos Inc's SIGNOS-CGM-EMPOWER-201-2022 study on weight loss and metabolic syndrome is currently …
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes [Phase 2]
Phase 2 study of LY3549492 in adults with obesity or overweight with type 2 diabetes has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI
This clinical trial update reports the completion of a study evaluating anti-thrombotic and glucose-lowering therapy in patients with type 2…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Effectiveness of Diabetes Self-management Education on Glycaemic Control in Patients With T2DM [NA]
This clinical trial update evaluates the effectiveness of diabetes self-management education in improving glycemic control in adults with ty…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Culturally Tailored Nutrition Therapy to Improve Dietary Adherence of Type 2 Diabetes Patients in Benin, Africa [NA]
A clinical trial in Benin evaluating culturally tailored nutrition therapy to improve dietary adherence in adults with Type 2 Diabetes; the …
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition
This clinical trial update notes that the study has completed and evaluated an oral nutritional supplement in adults with type 2 diabetes me…